Posts Tagged ‘FDA’

Year
Month
Category
Clear Filters
High Wire Act

Setting a Higher Bar for Dietary Supplements

April 5, 2017

Health & Obesity, Health Policy

A remarkable collaboration is taking shape to set a higher bar for the quality and safety of dietary supplements. This week in Washington the Dietary Supplement Quality Collaborative (DSQC) brought together people from the supplement industry with consumer advocates, health professionals, and scientific organizations. This group has been taking shape over the last year. The shared […]

Read More
Healthy Carrot Oatmeal Bites

Little Snack Bar Takes On Big Food

February 17, 2017

Health & Obesity, Health Policy

It’s a perfect narrative. A brave entrepreneur making healthy snack bars is putting his money on the line to bring us truth in nutrition. Daniel Lubetzky, founder and owner of Kind Bars LLC, announced Tuesday that he is funding the creation of a new nonprofit. He will call it Feed the Truth. And thus, Little […]

Read More
Bones

Dietary Supplements: Sometimes a Placebo Is Better

January 31, 2017

Health & Obesity, Health Policy, Scientific Meetings & Publications

Dietary supplements live in a unique regulatory space. That space lies somewhere between food and drugs. Sometimes that’s just fine. Vitamins and minerals that your body really needs can be well-regulated for purity and safety. But therapeutic agents also squeeze into this space. For example, glucosamine and chondroitin supplements advertise benefits like “joint mobility.” People with […]

Read More
Path to the Future

Ten Expectations for 2017 in Obesity, Food, and Health

January 1, 2017

Health & Obesity, Health Policy, Scientific Meetings & Publications

The new year brings new expectations. Sure, we always have new diet, nutrition, and weight loss fashions. But, in thinking about obesity and health, we can also expect some more substantive changes. Here’s our top ten for 2017. 1. More “Less Added Sugar.” Already, the pressure to avoid sugar was on. Now, new labeling for added sugar will dial […]

Read More
Rose Milk

If They Call It Rose Milk, Will You Drink It?

December 22, 2016

Health & Obesity, Health Policy

Have you noticed that lots of milk doesn’t come from mammary glands these days? Eager to tap into consumer fancies, innovators are offering up just about any kind of plant-based milk you can imagine. Almond, soy, flax, rice, hazelnut, hemp, quinoa, and cashew milk are some of the options. For rose milk, you still have […]

Read More

A Rough Ride Despite Saxenda’s Success

October 31, 2016

Health & Obesity

Over the last four years, four new obesity meds gained approval and only one lived up to expectations in the marketplace – the Saxenda brand of liraglutide 3 mg from Novo Nordisk. The company reported quarterly results last week. Saxenda sales, growing impressively, are on track to surpass $200 million for the year. Net profit for […]

Read More
St John Ambulance

Unacceptable Liver Toxicity from Dietary Supplements

October 20, 2016

To understand the potential for harm from herbal and dietary supplements (HDS) for weight loss, consider this observation recently published in Hepatology: HDS-induced liver injury now accounts for 20% of cases of hepatotoxicity in the United States based on research data. The major implicated agents include anabolic steroids, green tea extract, and multi-ingredient nutritional supplements (MINS). This observation […]

Read More
Healthy

Healthy Labels, Healthy Food Sales, Healthy People?

October 5, 2016

FDA wants to know what it means to call a food product “healthy.” They have a definition that dates back to 1992. Based on that definition, fat-free, high carb foods counted as healthy. Foods with beneficial fats, like avocados and almonds, didn’t meet the definition. FDA Director Nutrition and Food Labeling Douglas Balentine knows that change […]

Read More

Targeting Obesity: Win Some, Lose Some

July 22, 2016

Targeting obesity with new treatments presents remarkable challenges. For evidence of this harsh reality, look at the sharply contrasting news this week for two potential new drugs: beloranib and setmelanotide. All work on beloranib was canceled by its developer, Zafgen. Almost simultaneously, Rhythm Pharmaceuticals published breakthrough results in the New England Journal of Medicine (NEJM) […]

Read More

Once-Daily Lorcaserin Approved. Now What?

July 21, 2016

Health & Obesity

Eisai and Arena Pharmaceuticals announced this week that they received final approval from FDA for once-daily lorcaserin, which will be sold as Belviq XR for long-term obesity treatment. The real question is: what will this mean for the product, the patients who can benefit from it, and for obesity care more broadly? This approval will […]

Read More

©2009-2026 ConscienHealth. All rights reserved. | Website Design by Mariela Antunes | Hosting by DTS